Lafontan, Max
Institut des Maladies Métaboliques et Cardiovasculaires,
France
2025 Rank: 27655
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 219 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27655 | 26966 |
| Total Cites | 12201 | 14192 |
| H-index | 56 | 65 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 570 | 598 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 2926 | 3208 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 4846 | 5485 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9122 | 9605 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.48 |
| Self-Citation Percentage |
14.03%
|
|
Lafontan, Max
Inserm,
France
2024 Rank: 25798
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 201 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25798 | 25091 |
| Total Cites | 11836 | 13822 |
| H-index | 56 | 65 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 547 | 575 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 2824 | 3105 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 4699 | 5336 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8818 | 9298 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.49 |
| Self-Citation Percentage |
14.37%
|
|
Lafontan, Max
Hôpital Rangueil,
France
2023 Rank: 24409
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 195 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24409 | 23565 |
| Total Cites | 11465 | 13450 |
| H-index | 55 | 64 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 515 | 543 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 2720 | 2999 |
| Number of Single+First+Last Authored Papers | 148 | 148 |
| Total Cites to Single+First+Last Authored Papers | 4583 | 5232 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8495 | 8968 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.50 |
| Self-Citation Percentage |
14.76%
|
|
Lafontan, Max
Hôpital Rangueil,
France
2022 Rank: 22839
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 183 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22839 | 21921 |
| Total Cites | 10928 | 12887 |
| H-index | 54 | 63 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 481 | 509 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 2585 | 2862 |
| Number of Single+First+Last Authored Papers | 148 | 148 |
| Total Cites to Single+First+Last Authored Papers | 4398 | 5045 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8038 | 8498 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.52 |
| Self-Citation Percentage |
15.20%
|
|
Lafontan, Max
Universite Paul Sabatier Toulouse III,
France
2021 Rank: 22181
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 573 out of 81805 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22181 | 20848 |
| Total Cites | 10624 | 12555 |
| H-index | 53 | 63 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 470 | 497 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 2510 | 2782 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 4283 | 4920 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7804 | 8255 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.52 |
| Self-Citation Percentage |
15.38%
|
|
Lafontan, Max
Universite Paul Sabatier Toulouse III,
France
2020 Rank: 20817
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 568 out of 69094 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20817 | 19952 |
| Total Cites | 9992 | 11905 |
| H-index | 53 | 61 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 430 | 457 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 2346 | 2621 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 4036 | 4677 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 7304 | 7750 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.54 |
| Self-Citation Percentage |
16.07%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.